Southern RNA is an Australian CDMO specialising in producing nucleic acid products that support the clinical development of ...

South African global pharmaceutical giant Aspen Pharmacare has found itself caught in Trump tariff-related market volatility, ...

We unpack the full scope of the U.S. budget cuts, from canceled clinical trials and stalled drug approvals to mass layoffs ...

Valued at a market cap of $9.6 billion, Cambridge, Massachusetts-based Moderna, Inc. (MRNA) is a biotechnology company that ...

Pfizer (NYSE:PFE) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a ...

The market has climbed by 5.8% over the past week, and is up 4.8% over the past year, with earnings expected to grow by 14% per annum in the coming years. Though the term 'penny stock' might sound ...

The YieldMax Magnificient 7 Fund of Option Income ETFs has outperformed the market since launch but I do not expect that to continue. Read the full stock report here.

Biotech is a dynamic industry that is driving scientific advances and innovation in healthcare. In Canada, the biotech sector ...

The company recently secured approval for olezarsen in FCS, and looks odds on for a follow-up approval in SHTG. Click here to ...

We recently published a list of 10 Best Multibagger Penny Stocks to Buy According to Billionaires. In this article, we are ...

The resignation of one of the FDA's top officials, Peter Marks, is worrying Wall Street as they await a replacement.